Scalar Market Research

Biologics Market Report Forecasts Impressive Growth by 2022 – Scalar Market Research

Are you interested in a 100% customized global market research report on Biologics Market Report?


Chicago, IL -- (SBWIRE) -- 09/22/2016 -- According to the report, "Biologics Market (2014 - 2022), By Products (Vaccines, Human Cells and Tissues, Gene Therapies, Xenotransplantation Products, Blood and Blood Product, Proteins and Allergenic Extracts), Source Materials (Avian Cell Culture, Bacteria, Transgenic, Yeast, Insect Cell Culture and Humans), Applications (Cancer, Diabetes, Rheumatoid Arthritis, and Anemia), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) - Global Opportunity Analysis and Industry Forecast", the market for biologics is expected to witness steady growth during the forecast period.

The biologics market report forecasts the revenue and growth trends for the global market. It also offers granular analysis of the market share and segmentation, along with the deeper understanding of the key drivers and restraints for this market.

Leaf through our data-driven infographic report on Global Biologics Market:

Buyers can avail 100% customization on this report, per our feasibility.

Enquiry Before Buying:

According to the biologics market report, the global market is expected to witness healthy growth during the forecast period. The report attributes this growth of the market to various driving factors. The major driving factors mentioned in the report include technological advancements and favorable government initiatives. Apart from that, strong rise in the instances of chronic diseases and expiry of patents are also some of the key driving factors for this market. The rapidly increasing research and development activities in this field are also expected to drive the growth of the global market. The major restraining factors include controlling the environmental factors, such as heat, moisture, and light.

The global biologics market report segments this market by the types of products, source materials, applications, and the major geographic regions. The types of products include human cells and tissues, vaccines, protein and allergenic extracts, blood and blood products, Xenotransplantation products, and gene therapies. The source material segments include bacteria, avian cell culture, humans, insect cell culture, yeast, and transgenic. The major application segments of the market include diabetes, cancer, anemia, and rheumatoid arthritis. The geographic regions include Europe, North America, Latin America, Asia-Pacific, and Middle East and Africa.

Request a Sample:

The key players mentioned in the biologics market report include AstraZenica, Bayer AG, Becton, Dickinson & Company, Genzyme Corporation, GlaxoSmithKline Biologicals, Lundbeck A/S, Merck KGaA, Novartis AG, H, Pfizer, Inc., Retractable Technologies, Inc., Terumo Corporation, Roche Diagnostics, Smiths Medical, Unilife Corporation, and such others. According to the report, the emerging markets are expected to present impressive business opportunities during the forecast period. North America is expected to dominate the global market based on the market share and revenue.

Browse Related Reports:

Biostimulants Market - Active Ingredients, Crop Types, Application Methods and Geography (2014 - 2022)

Biosimilars Market - Product Types, Applications and Geography (2013 - 2021)

About Scalar Market Research
Scalar Market Research Inc. aspires to assist organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers a crystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast.

Find out more about our services at:

Mr. Rahul Ganju
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: 800-213-5170 (U.S./Canada Toll-free)